Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Paige Wells

Physician Assistant Jupiter, FL Physician Assistant

NPI 1740787183 CMS profile 4724312

4600 Military Trl Ste 107, Jupiter, FL 33458

Open in the dashboard

General payments

$20,090

845 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paige Wells of Jupiter, FL is reported in the CMS Open Payments database as having received $20,090 across 845 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $160 4
2024 General $4,605 182
2023 General $5,648 239
2022 General $4,383 205
2021 General $5,294 215

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paige Wells
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Paige Wells were reported at $160. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Paige Wells Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $5,294 $132 $37–$438 $132
2022 $4,383 $155 $48–$522 $149
2023 $5,648 $167 $52–$557 $160
2024 $4,605 $178 $55–$600 $164
2025 $160 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $3,035 121 payments
  2. Janssen Biotech, Inc. $1,623 74 payments
  3. Dermavant Sciences, Inc. $1,419 23 payments
  4. Galderma Laboratories, L.P. $1,272 109 payments
  5. LEO Pharma Inc. $1,227 24 payments
  6. Lilly USA, LLC $1,205 44 payments
  7. Janssen Scientific Affairs, LLC $993 9 payments
  8. Novartis Pharmaceuticals Corporation $909 54 payments
  9. Genzyme Corporation $853 36 payments
  10. Arcutis Biotherapeutics, Inc. $826 38 payments
  11. Other $6,727 313 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $17,999 836 payments
  2. Consulting Fee $1,575 2 payments
  3. Education $270 3 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $246 4 payments
Products named General payments · program years 2021–2025
  1. TREMFYA $2,615 83 payments
  2. SKYRIZI $1,535 65 payments
  3. VTAMA $1,419 23 payments
  4. DUPIXENT Immunology $969 41 payments
  5. RINVOQ $957 39 payments
  6. TALTZ $883 41 payments
  7. OPZELURA $722 36 payments
  8. DUPIXENT Inflammation And Immunology $612 18 payments
  9. CIBINQO $579 28 payments
  10. HUMIRA $559 20 payments
  11. Other $9,728 544 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

845 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record